These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Combination of FDG PET/CT and contrast-enhanced MSCT in detecting lymph node metastasis of esophageal cancer. Tan R; Yao SZ; Huang ZQ; Li J; Li X; Tan HH; Liu QW Asian Pac J Cancer Prev; 2014; 15(18):7719-24. PubMed ID: 25292052 [TBL] [Abstract][Full Text] [Related]
5. Clinical usefulness of dual-time FDG PET-CT in assessment of esophageal squamous cell carcinoma. Shum WY; Hsieh TC; Yeh JJ; Chen JH; Su CC; Liang JA; Kao CH Eur J Radiol; 2012 May; 81(5):1024-8. PubMed ID: 21458941 [TBL] [Abstract][Full Text] [Related]
6. Axillary Lymph Node Metastasis as the First Symptom of Colon Cancer. Zhao W; Li P; Li Y; He Y; Yang J Clin Nucl Med; 2023 Dec; 48(12):1117-1118. PubMed ID: 37846156 [TBL] [Abstract][Full Text] [Related]
7. Sensitivity and specificity of FDG PET-CT scan in detecting lymph node metastasis in operable periampullary tumours in correlation with the final histopathology after curative surgery. Raj P; Kaman L; Singh R; Dahyia D; Bhattacharya A; Bal A Updates Surg; 2013 Jun; 65(2):103-7. PubMed ID: 23504604 [TBL] [Abstract][Full Text] [Related]
8. The diagnostic accuracy of fluorodeoxyglucose-positron emission tomography/computed tomography and sentinel node biopsy in the prediction of pelvic lymph node metastasis in patients with endometrial cancer: A retrospective observational study. Tanaka T; Terai Y; Yamamoto K; Yamada T; Ohmichi M Medicine (Baltimore); 2018 Sep; 97(38):e12522. PubMed ID: 30235772 [TBL] [Abstract][Full Text] [Related]
9. F-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography Has High Diagnostic Value for Pelvic and Distant Staging in Patients with High-risk Penile Carcinoma. Ottenhof SR; Djajadiningrat RS; Versleijen MWJ; Donswijk ML; van der Noort V; Brouwer OR; Graafland NM; Vegt E; Horenblas S Eur Urol Focus; 2022 Jan; 8(1):98-104. PubMed ID: 33685842 [TBL] [Abstract][Full Text] [Related]
10. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer? Schaefferkoetter JD; Carlson ER; Heidel RE J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746 [TBL] [Abstract][Full Text] [Related]
11. The value of dual-time-point 18F-FDG PET/CT for identifying axillary lymph node metastasis in breast cancer patients. Choi WH; Yoo IR; O JH; Kim SH; Chung SK Br J Radiol; 2011 Jul; 84(1003):593-9. PubMed ID: 21081574 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients. An YS; Lee DH; Yoon JK; Lee SJ; Kim TH; Kang DK; Kim KS; Jung YS; Yim H Nuklearmedizin; 2014; 53(3):89-94. PubMed ID: 24220324 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography combined with ultrasonography-guided fine needle aspiration cytology for identifying axillary lymph node status in patients with breast cancer. Machida Y; Kubota K; Katayama T; Toriihara A; Shibuya H Eur J Surg Oncol; 2013 Jan; 39(1):26-30. PubMed ID: 23122913 [TBL] [Abstract][Full Text] [Related]
14. The peak-standardized uptake value (P-SUV) by preoperative positron emission tomography-computed tomography (PET-CT) is a useful indicator of lymph node metastasis in gastric cancer. Oh HH; Lee SE; Choi IS; Choi WJ; Yoon DS; Min HS; Ra YM; Moon JI; Kang YH J Surg Oncol; 2011 Oct; 104(5):530-3. PubMed ID: 21618250 [TBL] [Abstract][Full Text] [Related]
15. DaPeCa-7: comparative assessment of fluorodeoxyglucose positron emission tomography/computed tomography (CT) and conventional diagnostic CT in diagnosis of lymph node metastases, distant metastases and incidental findings in patients with invasive penile cancer. Jakobsen JK; Frahm Nielsen T; Ipsen P; Albrecht-Beste E; Cardoso Costa J; Alslev L; Predbjørn Krarup K; Grønkaer Toft B; Høyer S; Bouchelouche K; Bjerggaard Jensen J BJU Int; 2021 Feb; 127(2):254-262. PubMed ID: 33448605 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of FDG-PET for lymph node metastasis and outcome of surgery for biliary cancer. Kobayashi S; Nagano H; Hoshino H; Wada H; Marubashi S; Eguchi H; Takeda Y; Tanemura M; Kim T; Shimosegawa E; Hatazawa J; Doki Y; Mori M J Surg Oncol; 2011 Mar; 103(3):223-9. PubMed ID: 21140426 [TBL] [Abstract][Full Text] [Related]
17. Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study. Zhai X; Guo Y; Qian X Med Sci Monit; 2020 Jun; 26():e922675. PubMed ID: 32483109 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study. Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients. Herbrik M; Treffert J; Geiger B; Riegger C; Hartung V; Rosenbaum-Krumme SJ; Forsting M; Antoch G; Heusner TA J Nucl Med; 2011 Oct; 52(10):1520-5. PubMed ID: 21908390 [TBL] [Abstract][Full Text] [Related]
20. FDG PET-CT in cervical cancer: relationship between primary tumor FDG uptake and metastatic potential. Yilmaz M; Adli M; Celen Z; Zincirkeser S; Dirier A Nucl Med Commun; 2010 Jun; 31(6):526-31. PubMed ID: 20215979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]